Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

26 May 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Surgical Treatments
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 20501503
DOI: 10.1093/annonc/mdq258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patientsPMID 20501503Read ↗

Mutation in BRAF V600E: A Poor Prognostic Marker in Stage III Colon Cancers With Deficient MMR?Semantic proximity Read ↗

KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147.Semantic proximity Read ↗

Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer.Semantic proximity Read ↗

Prognostic and clinicopathologic significance of BRAF mutation in colon cancer by MSI status and stage: A large cohort analysis.Semantic proximity Read ↗

Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.Semantic proximity Read ↗

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.Semantic proximity Read ↗

Prognostic impact of mutation profiling in patients with stage II and III colon cancer.Semantic proximity Read ↗

BRAF V600E Mutation as a Negative Prognostic Determinant in Resected Colorectal Liver Metastases.Semantic proximity Read ↗

Prognostic Factors for Survival in Transverse Colon Cancers.Semantic proximity Read ↗

Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer.Semantic proximity Read ↗

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.